The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures

The Journal of Antimicrobial Chemotherapy
Y ShadkhanD Lichtenberg

Abstract

The use of Intralipid as a dilution medium for Fungizone, previously proposed by several groups to reduce the toxicity of amphotericin B, is limited by the instability of amphotericin B-lipid admixtures. We have shown that Fungizone-lipid admixtures with three different lipid emulsions can be stabilized by vigorous agitation. Unlike in preparations made by gentle shaking, in stable emulsions made by agitation for 18 h, most of the amphotericin B remains associated with the lipid phase for at least 1 month at 4 degrees C. The MICs of all the admixtures against various Candida spp. were similar to that of Fungizone and did not change following storage for at least 2 weeks at 4 degrees C. Furthermore, the toxicity of the admixtures, as evaluated by their haemolytic activity and amphotericin B-induced K+-leakage from human red blood cells, was much lower than that of Fungizone. Hence, amphotericin B-containing lipid emulsions made by extended agitation may be advantageous in clinical practice as they are efficient, stable, non-toxic and can be easily produced at low cost from commercially available ingredients approved for clinical use.

Citations

Jan 7, 2004·International Journal of Pharmaceutics·R H MüllerS Brömer
Mar 5, 2003·International Journal of Pharmaceutics·Sven Schmidt, Rainer H Müller
Sep 5, 2003·International Journal of Pharmaceutics·Hiroshi FukuiJunzo Seki
May 3, 2011·Chemical & Pharmaceutical Bulletin·Mohammad Sayed AlamDong-Ung Lee
Apr 3, 2012·Chemical & Pharmaceutical Bulletin·Azza Taher Taher, Amira Atef Helwa
Oct 24, 2012·Medical Mycology·Rita SemisEsther Segal
May 6, 2004·Medical Mycology·Y ShadkchanE Segal
Oct 16, 2002·Journal of Pharmaceutical Sciences·E Sócrates T EgitoJames C Price
May 20, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A Akkar, R H Müller
Aug 16, 2011·International Journal of Antimicrobial Agents·R SemisE Segal
Jun 17, 2004·AAPS PharmSciTech·Aslihan AkkarRainer H Müller
Dec 4, 2003·FEMS Immunology and Medical Microbiology·Edward Sionov, Esther Segal
Aug 17, 2005·Infectious Disease Clinics of North America·P Brian SmithDaniel K Benjamin
May 19, 2006·International Journal of Antimicrobial Agents·Pranatharthi Chandrasekar
Sep 20, 2011·Analytical Biochemistry·Steven R InglisChristopher J Schofield
Dec 11, 1999·The Journal of Antimicrobial Chemotherapy·Y Shadkchan, E Segal
Jul 12, 2005·The Journal of Antimicrobial Chemotherapy·Edward SionovEsther Segal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.